CAS 153012-37-4

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-thiazolyl]-1-oxo-2-penten-1-yl]amino]-8-oxo-, (6R,7R)-, compd. with N-(1-methylethyl)-2-propanamine (1:1)

Description:

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-thiazolyl]-1-oxo-2-penten-1-yl]amino]-8-oxo-, (6R,7R)-, compd. with N-(1-methylethyl)-2-propanamine is a complex organic compound characterized by its bicyclic structure, which includes a thiazole and an azabicyclic framework. This compound features multiple functional groups, including carboxylic acid, amine, and carbonyl moieties, contributing to its potential biological activity. The presence of stereocenters indicates chirality, which may influence its pharmacological properties. The compound is likely to exhibit solubility in polar solvents due to its functional groups, and its stability may be affected by environmental conditions such as pH and temperature. Given its intricate structure, it may interact with biological targets, making it of interest in medicinal chemistry. The specific interactions and mechanisms of action would require further investigation through experimental studies. Overall, this compound represents a unique class of chemical entities with potential applications in drug development.

Formula: C₂₂H₂₇N₅O₈S₂·C₆H₁₅N

InChI: InChI=1S/C22H27N5O8S2.C6H15N/c1-5-6-11(12-9-37-20(24-12)26-21(33)35-22(2,3)4)15(28)25-13-16(29)27-14(18(30)31)10(7-34-19(23)32)8-36-17(13)27;1-5(2)7-6(3)4/h6,9,13,17H,5,7-8H2,1-4H3,(H2,23,32)(H,25,28)(H,30,31)(H,24,26,33);5-7H,1-4H3/b11-6-;/t13-,17-;/m1./s1

InChI key: InChIKey=QYEZISGUDCJQMM-RWLWEFMLSA-N

SMILES: C(O)(=O)C=1N2[C@@]([C@H](NC(/C(=C\CC)/C=3N=C(NC(OC(C)(C)C)=O)SC3)=O)C2=O)(SCC1COC(N)=O)[H].N(C(C)C)C(C)C

Synonyms:

• 2-Propanamine, N-(1-methylethyl)-, [6R-[6α,7β(Z)]]-3-[[(aminocarbonyl)oxy]methyl]-7-[[2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-thiazolyl]-1-oxo-2-pentenyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
• 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-thiazolyl]-1-oxo-2-penten-1-yl]amino]-8-oxo-, (6R,7R)-, compd. with N-(1-methylethyl)-2-propanamine (1:1)
• 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-thiazolyl]-1-oxo-2-pentenyl]amino]-8-oxo-, [6R-[6α,7β(Z)]]-, compd. with N-(1-methylethyl)-2-propanamine (1:1)
• BCN
• Cefcapene Intermediate
• Cefcapene pivoxil intermediate
• Intermediate of Cefcapene

Precursor of cefcapene diisopropylanmine salt

Controlled Product

CAS: 153012-37-4

The Precursor of cefcapene diisopropylanmine salt is a potent anticancer agent with promising medicinal properties. It has been shown to induce apoptosis in human cancer cells and Chinese hamster ovary cells, making it a potential analog for cancer treatment. This compound is excreted through urine and has protein kinase inhibitor activity, which may contribute to its anticancer effects. The Precursor of cefcapene diisopropylanmine salt inhibits the activity of kinases that are involved in the regulation of cell growth and differentiation, making it a promising candidate for cancer therapy. Its ability to inhibit tumor growth makes it an attractive target for further research into novel cancer treatments.

Formula: C₂₉H₄₃N₅O₈S₂

Purity: Min. 95%

Molecular weight: 653.8 g/mol

Ref: 3D-DGA01237

N-Boc Cefcapene N,N-Diisopropylamine

CAS: 153012-37-4

Formula: C₂₂H₂₇N₅O₈S₂C₆H₁₅N

Molecular weight: 553.61 : 101.19

Ref: ST-EA-CP-C608006